Nautilus Biotechnology, Inc.
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Nautilus Biotechnology, Inc.
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Largest filed tie
0
filed ties
Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied
Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. It develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. The company was founded in 2016 and is headquartered in Seattle, Washington.
Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. It develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. The company was founded in 2016 and is headquartered in Seattle, Washington.
No other changes.
No other changes.
Annual filing, covered
10-K parsed · Feb 26 '26
Supply-chain ties, covered
None disclosed
Fund holders, covered
N-PORT holdings
13F holdings, covered
13F quarter · Jun 30 '26
Management, not covered
Not covered · DEF 14A, 8-K 5.02
Company IR feed, not covered
News via newswires & EDGAR
Products, patents, hiring, not covered
Not covered
Annual filing, covered
10-K parsed · Feb 26 '26
Supply-chain ties, covered
None disclosed
Fund holders, covered
N-PORT holdings
13F holdings, covered
13F quarter · Jun 30 '26
Management, not covered
Not covered · DEF 14A, 8-K 5.02
Company IR feed, not covered
News via newswires & EDGAR
Products, patents, hiring, not covered
Not covered
No thesis.
Nautilus Biotechnology, Inc.
2.36
pre 2.34 −0.43%
Same SIC code · 6
Same SEC industry code: Agilent Technologies, Inc., Waters Corp, Mettler Toledo International Inc/ and 3 more; no measured co-movers for Nautilus Biotechnology, Inc..
Same SIC code · 6
Same SEC industry code: Agilent Technologies, Inc., Waters Corp, Mettler Toledo International Inc/ and 3 more; no measured co-movers for Nautilus Biotechnology, Inc..
Tall tick = annual report · Source: EDGAR
| Manager | Value | % base | |
|---|---|---|---|
| Perceptive | $21.8M | 23.20% | −7.62% |
| AH Capital Management | $16.9M | 18.07% | −48.66% |
| Cercano | $13.4M | 14.30% | 0.00% |
| BlackRockindex-like | $5.0M | 5.36% | +1331.88% |
| Vanguardindex-like | $4.8M | 5.08% | +0.17% |
| Manager | Value | % base | |
|---|---|---|---|
| Perceptive | $21.8M | 23.20% | −7.62% |
| AH Capital Management | $16.9M | 18.07% | −48.66% |
| Cercano | $13.4M | 14.30% | 0.00% |
| BlackRockindex-like | $5.0M | 5.36% | +1331.88% |
| Vanguardindex-like | $4.8M | 5.08% | +0.17% |
Bull2
Bear2
Expected move
Inputsspot 2.35exp Mar 19ATM strike 2.5ATM straddle 1.60IV 141%